The Lancet 2015 PURE Study: What It Found
The Prospective Urban Rural Epidemiology (PURE) study, published in The Lancet in May 2015, is the largest cross-national study ever conducted on grip strength and mortality outcomes. Led by Darryl Leong and colleagues, the study enrolled 139,691 adults aged 35–70 across 17 countries spanning low-, middle-, and high-income economies, with a median follow-up of 4 years.
The primary finding was stark: grip strength was inversely associated with all-cause mortality, cardiovascular mortality, non-cardiovascular mortality, myocardial infarction, and stroke. Crucially, the magnitude of the association exceeded that of systolic blood pressure — which had long been considered the gold-standard modifiable vital sign for cardiovascular risk.
Key finding: Each 5 kg decrement in grip strength was associated with a 17% higher risk of cardiovascular death (HR 1.17, 95% CI 1.11–1.24), a 16% higher all-cause mortality risk (HR 1.16, 95% CI 1.13–1.20), and increased risk of myocardial infarction (HR 1.07) and stroke (HR 1.09). These associations held after adjusting for age, sex, education, physical activity, tobacco use, and country income level.
The PURE authors explicitly noted that grip strength "may be a stronger predictor of cardiovascular mortality than systolic blood pressure" — a statement that upended decades of clinical habit. Blood pressure is measured at virtually every medical encounter worldwide. Grip strength is measured almost nowhere.
The study used a Jamar hydraulic hand dynamometer, the clinical standard, measuring dominant hand grip in kilograms with participants seated, elbow at 90 degrees. Three trials were averaged. This is the protocol you should replicate for self-monitoring.
Why Grip Strength Reflects Systemic Muscle Quality — Not Just Hand Strength
A common misconception is that grip strength is simply a measure of forearm musculature. In reality, it is a composite biomarker of systemic skeletal muscle quality, representing the integrated output of multiple biological systems.
Neuromuscular Integrity
Force production in any muscle group requires the synchronous recruitment of motor units — a process regulated by the central and peripheral nervous system. Grip strength captures neuromuscular efficiency globally. Individuals with subclinical peripheral neuropathy, declining motor neuron density, or reduced central drive will show measurable grip deficits before overt neurological symptoms appear.
Protein Synthesis Capacity
Skeletal muscle is the body's largest reservoir of amino acids and the primary site of protein turnover. Grip strength correlates with whole-body lean mass (r ≈ 0.70 in population studies) and reflects the anabolic/catabolic balance across all muscle tissue. Chronic disease states — cancer, heart failure, chronic kidney disease, COPD — all produce systemic catabolism that manifests measurably in grip decline before body weight changes become apparent.
Inflammatory Load
A 2020 meta-analysis in Ageing Research Reviews (Li et al., n=40,560) found that low grip strength was consistently associated with elevated circulating IL-6 and CRP. Skeletal muscle produces anti-inflammatory myokines (IL-15, irisin, BDNF) during contraction — loss of muscle mass reduces this endocrine function, permitting chronic low-grade inflammation to escalate. The grip dynamometer, in other words, captures inflammatory biology indirectly.
Mitochondrial Density
Force output at maximal contraction correlates with mitochondrial number and efficiency in skeletal muscle. A 2018 study in Nature Communications (Guralnik et al.) demonstrated that grip strength declined in parallel with skeletal muscle mitochondrial oxidative capacity across an aging cohort, and that both predicted 10-year survival independently of each other.
Normative Grip Strength Values by Age and Sex
Knowing your grip number means nothing without context. The following normative ranges are drawn from the Southampton Longitudinal Study (Syddall et al.), the NHANES 2011–2012 dataset (Dodds et al., 2014), and the EWGSOP2 sarcopenia criteria. All values reflect dominant-hand grip in kilograms using a Jamar dynamometer.
| Age Range | Men — Optimal (kg) | Men — Low Risk Threshold | Women — Optimal (kg) | Women — Low Risk Threshold |
|---|---|---|---|---|
| 30–39 | 52–56 | >46 | 32–34 | >28 |
| 40–49 | 50–54 | >44 | 31–33 | >27 |
| 50–59 | 46–50 | >40 | 28–31 | >24 |
| 60–69 | 40–45 | >35 | 25–28 | >21 |
| 70–79 | 34–39 | >29 | 21–24 | >17 |
| 80+ | 27–32 | >22 | 17–20 | >14 |
Source: Dodds et al. (2014) NHANES; EWGSOP2 2019. Values are approximate and population-weighted. Clinical decisions require practitioner input.
The EWGSOP2 (2019) — the European clinical consensus on sarcopenia — uses grip strength below 27 kg in men and 16 kg in women as the primary diagnostic threshold for "probable sarcopenia." At or below these values, the guideline recommends full body composition assessment and functional mobility testing.
Evidence Table: Grip Strength Category, Mortality Risk, and Major Cohorts
| Grip Strength Category | Mortality Risk | Study | N / Follow-up |
|---|---|---|---|
| Highest quartile | Referent (lowest risk) | Leong et al. — Lancet PURE (2015) | 139,691 / 4 yr |
| Lowest quartile (vs. highest) | HR 1.67 all-cause; HR 2.10 CV death | Leong et al. — Lancet PURE (2015) | 139,691 / 4 yr |
| Per 5 kg decline | +16% all-cause, +17% CV death | Leong et al. — Lancet PURE (2015) | 139,691 / 4 yr |
| Low grip (<30 kg men; <20 kg women) | HR 1.82 all-cause mortality | Bohannon — J Geriatr Phys Ther (2019) meta-analysis | ~500,000 pooled |
| Lowest tertile | 2× 10-yr mortality vs. highest | Cooper et al. — BMJ (2010) | 6,913 / 10 yr |
| Per SD decrease in grip | +20% all-cause, +26% CV death | Celis-Morales et al. — BMJ (2018) | 502,536 UK Biobank / 7 yr |
| Lowest quintile | HR 2.43 cancer mortality | Celis-Morales et al. — BMJ (2018) | 502,536 UK Biobank / 7 yr |
| Grip decline >5 kg over 3 yr | HR 1.44 vs. stable grip | Strand et al. — Age Ageing (2016) | 4,130 / 12 yr |
The UK Biobank data (Celis-Morales et al., BMJ, 2018) deserves particular attention. With over 500,000 participants and seven years of follow-up, it represents the largest prospective cohort examining this relationship in a predominantly high-income Western population. The finding that the lowest grip quintile carried a 2.43× higher cancer mortality risk suggests that the mechanism extends well beyond cardiovascular disease — likely through immune surveillance, inflammatory signaling, and metabolic health.
Gait Speed: The Parallel Predictor
Grip strength does not stand alone. Walking speed — specifically the 4-meter gait speed test — is its most important companion biomarker. Together, these two measurements constitute the functional core of the Short Physical Performance Battery (SPPB) and the SARC-F sarcopenia screening tool.
A pivotal 2011 meta-analysis in JAMA (Studenski et al.) pooled individual patient data from nine cohort studies totaling 34,485 adults aged 65 and older. The key findings:
- Gait speed below 0.8 m/s over a 4-meter course was associated with significantly higher mortality at 10 years.
- Each 0.1 m/s improvement in gait speed was associated with a 12% lower mortality hazard.
- Gait speed predicted survival as accurately as age, chronic conditions, cognitive status, and blood pressure combined.
Clinical benchmark: A comfortable walking pace above 1.0 m/s (roughly 2.2 mph) is considered normal for adults under 75. Below 0.6 m/s, the risk gradient increases sharply. Measure yours by timing a 4-meter walk at your normal pace, then divide 4 by your seconds.
The mechanistic overlap between grip and gait speed is important: both reflect the integrity of lower and upper extremity muscle function, motor neuron density, proprioceptive accuracy, and the metabolic capacity to sustain contractile effort. A 2019 study in The Journals of Gerontology (Cawthon et al.) found that adults in the lowest tertile of both grip strength and gait speed had a 3.6× higher 10-year mortality risk than those in the highest tertile of both measures — a synergistic risk amplification that no single biomarker alone captures.
Sarcopenia: The Clinical Framework Linking Grip to Aging Biology
Sarcopenia — derived from the Greek for "poverty of flesh" — was formally recognized as an independent disease in 2016 (ICD-10-CM code M62.84). The EWGSOP2 consensus (Cruz-Jentoft et al., Age and Ageing, 2019) defines it as a progressive, generalized skeletal muscle disorder involving accelerated loss of muscle mass and function, associated with adverse outcomes including falls, functional decline, frailty, and premature death.
The diagnostic algorithm begins with a grip strength measurement:
- Step 1 — Screen: Use the SARC-F questionnaire (5 questions, score 0–10; score ≥4 = probable sarcopenia).
- Step 2 — Assess: Measure grip strength. Men below 27 kg or women below 16 kg = probable sarcopenia.
- Step 3 — Confirm: Dual-energy X-ray absorptiometry (DXA) or bioelectrical impedance analysis (BIA) to quantify appendicular lean mass index (ALMI). Men <7.0 kg/m², women <5.5 kg/m² = confirmed sarcopenia.
- Step 4 — Severity: Gait speed below 0.8 m/s or SPPB score ≤8 = severe sarcopenia.
Prevalence data from the InCHIANTI cohort (Ferrucci et al.) and the EPIDOS cohort suggest sarcopenia affects 5–10% of adults in their 60s, 15–20% in their 70s, and over 50% of adults past age 80. The economic and functional burden is substantial: a 2022 analysis in JAMDA estimated sarcopenia-related hospitalization costs in the US at $40.4 billion annually.
How to Improve Grip Strength: Evidence-Based Methods
The critical insight is that grip strength is trainable — including in older adults. A 2017 systematic review and meta-analysis in Age and Ageing (Westcott, n=1,079 across 18 RCTs) found that resistance training increased grip strength by an average of 1.8–4.1 kg over 12 weeks in adults aged 55–80. This magnitude of gain corresponds to a clinically meaningful shift on the mortality risk curve.
Dead Hangs
Hanging from a pull-up bar with straight arms (passive hang) creates sustained isometric loading of the entire grip-forearm complex and decompresses the shoulder capsule simultaneously. Begin with 3 sets of 15–20 seconds and progress toward 60-second holds over 8 weeks. A 2020 study in the Journal of Strength and Conditioning Research found dead hang training produced superior grip gains compared to grip trainers alone when volume was equated — likely due to the continuous high-load isometric stimulus.
Farmer Carries
Farmer carries involve walking a set distance (30–50 meters) while holding heavy dumbbells or kettlebells at your sides. The grip is under constant eccentric and isometric stress while the entire posterior chain and core stabilize the load. Progressive loading over 8–12 weeks (starting at 40–50% bodyweight total load, advancing toward bodyweight) produces measurable dynamometer gains in both forearm endurance and peak force. Farmer carries also load the traps, erectors, and glutes — making them among the highest return-per-set exercises for total-body functional strength.
Fat Grip Training
Fat grip attachments (typically 2.5-inch diameter silicone sleeves placed over standard bars) dramatically increase forearm muscle recruitment by preventing digit flexor tendons from completing a comfortable wrap around the bar. This forces deeper recruitment of the extensor digitorum communis and pronator teres. Research from the University of Calgary (Ratcliffe et al., 2019) found that eight weeks of fat-grip barbell training increased maximal grip force by 23% compared to 14% with standard grip training on matched volume.
Towel Pull-Ups and Rope Climbs
Hanging a gym towel over a pull-up bar and performing pull-ups with one or two towels creates an unstable, high-demand grip surface that maximally recruits the intrinsic hand muscles. Rope climbs are the single highest-intensity grip exercise available — a single set to failure produces acute grip fatigue that no other exercise matches. Both are appropriate only after baseline grip endurance is established through dead hangs and farmer carries.
Progressive Resistance Grip Trainers
Adjustable progressive grip trainers allow isolated high-repetition training of the finger flexors, useful for recovery days or for individuals who cannot yet dead hang. The key is progressive overload — starting at a resistance that allows 15–20 clean repetitions and adding resistance every 2–3 weeks. High-repetition grip training at moderate resistance (above 30% of maximal voluntary contraction) has been shown to improve both endurance and peak force in elderly populations (Incel et al., Rheumatol Int, 2002).
Testing Protocol: How to Use a Hand Dynamometer Correctly
For data that is comparable to clinical norms and Lancet-protocol studies, standardize your measurement:
- Seat the subject with the shoulder adducted, elbow flexed at 90°, forearm neutral (thumb up), wrist in slight extension (0–30°).
- Adjust the handle so the second joint of the middle finger sits under the top arm of the dynamometer. This position maximizes mechanical advantage and matches Jamar protocol.
- Three trials per hand, alternating hands between trials, with 60-second rest between same-hand trials.
- Record the average of three trials for the dominant hand as your primary metric.
- Test at the same time of day — grip peaks in late morning and drops in early morning and late evening. Circadian variation can be 2–4 kg in healthy adults.
- Track quarterly — 12 weeks is the minimum interval for meaningful training-induced change to be detected above measurement noise.
This protocol is informational. Consult a qualified physician or physical therapist before beginning a resistance training program, particularly if you have cardiovascular, orthopedic, or neuromuscular conditions.